13

/

en

AIzaSyCYaC8UkdPkQKLFUmpasLV5eC3M802CrcA

14020

2

14983

Create Recently updated Popular Library FAQ Get Premium for free!

Export

Duplicate

Embed

asdfg

Created by Daniel Rossi

Comments

59 views

0

0

Updated

Events

Founded as Genetix Pharmaceuticals Jesse Gelsinger Dies, Interest Lost in Gene Therapy Series A Financing, $20 million raised Phase I/II Beta Thallassemia trial launched Genetix Launches ADL Program Series B, $35 million raised, new CEO from Third Rock Ventures Series C, $35 million Series D, $60 million Initial Public Offering, $116 million Cash assets expected to run out Phase 3 End Date, Beta Thalassemia Phase 2/3 end date, ALD

Browse

Recently updated Popular Library FAQ Premium

What's new

Share

Share on Google+Share on Facebook Submit to Reddit Share on LinkedIn Pin it Post to Tumblr Tweet

© 2018

Feedback About Terms Privacy

English